Skip to main content
    O

    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC)

    Official site

    FINANCIAL SERVICES • SHELL COMPANIES • NASDAQ

    $10.72
    +0.02 (+0.19%)

    Market Cap: $141.79M

    Last updated: Nov 17, 2026 at 4:00 PM ET

    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share (OACC) has a market cap of $141.79M and an enterprise value of $140.58M. Its return on invested capital of 27.59% compares with a 14.38% median across 4 similar companies.

    Total Valuation

    Enterprise value is 0.86% below the market cap, as cash exceeds debt.

    Market Cap$141.79M
    Enterprise Value$140.58M
    Close (Nov 17, 2026)$10.72

    Key Dates

    Last Earnings DateAug 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 4.70% a year over 2 years.

    Shares Outstanding24.58M
    Shares Change (YoY)0.00%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+4.70%

    Price Statistics

    The stock is up 1.13% over 52 weeks and trades 0.19% below its 50-day average.

    Beta (1Y)0.02
    52-Week Change+1.13%
    1-Month Change+0.66%
    3-Month Change-0.19%
    6-Month Change+0.19%
    Total Return (1Y)+1.13%
    Return vs SPY (1Y)-10.33%
    Max Drawdown (1Y)-2.56%
    Sharpe Ratio (1Y)0.25
    Correlation with SPY (1Y)0.04
    50-Day Average$10.74
    200-Day Average$10.70
    52-Week Range$10.50 to $10.93
    RSI (14 Days)51.9
    Average Volume (20 Days)1.83K

    Financial Position

    Current assets cover 0.32x current liabilities.

    Current Ratio0.32x
    Quick Ratio0.32x

    Returns and Efficiency

    Return on invested capital is 27.59% over the last 12 months.

    Return on Assets (ROA)2.08%
    Return on Invested Capital (ROIC)27.59%

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Operating Income-$3.36M
    Pretax Income$4.34M
    Net Income$4.34M
    Reported EPS (TTM)$0.27

    Trailing 12 months through Sep 30, 2026.

    Balance Sheet

    Cash and Equivalents$1.23M
    Total Debt$11.82K
    Net Cash$1.21M
    Net Cash Per Share$0.05
    Working Capital-$2.60M
    Shareholder Equity-$9.62M
    Total Assets$208.21M
    Total Liabilities$10.87M

    Balance sheet as of Sep 30, 2026.

    Cash Flow

    Operating Cash Flow-$603.24K
    FCF Per Share-$0.05

    Trailing 12 months through Sep 30, 2026.

    Dividends and Yields

    OACC does not pay a dividend.

    Earnings Yield2.56%
    Shareholder Yield0.00%

    Peer Position

    Against 8 similar companies, OACC has the 8th highest P/E.

    P/E Ratio39.0x vs 44.4x median
    ROIC27.59% vs 14.38% median

    Competitors compared

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About OACC

    What is OACC's market cap?

    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share has a market cap of $141.79M. Its enterprise value, which adds debt and subtracts cash, is $140.58M.

    What is OACC's P/E ratio?

    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share has a trailing P/E ratio of 39.0x.

    How many shares of OACC are outstanding?

    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share has 24.58M shares outstanding. The count is up 0.00% from a year earlier.

    Does OACC pay a dividend?

    No. Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share does not pay a dividend.

    How much debt does OACC have?

    Oaktree Acquisition Corp. III Life Sciences Class A Ordinary Share has $11.82K of total debt and $1.23M of cash and equivalents, a net cash position of $1.21M.